Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
数字之外：6位分析师讨论默沙东股票
During the last three months, 6 analysts shared their evaluations of Merck & Co (NYSE:MRK), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，6家分析师分享了他们对默沙东的评估（NYSE:MRK），展示了看好到看淡的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $146.17, a high estimate of $155.00, and a low estimate of $134.00. This current average reflects an increase of 0.34% from the previous average price target of $145.67.
分析师通过他们对未来12个月股价目标的评估提供更深入的见解，显示出平均目标为146.17美元，最高估价为155.00美元，最低估价为134.00美元。这个当前平均值比以前的平均目标价格145.67美元增长了0.34%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
The perception of Merck & Co by financial experts is analyzed...
通过分析最近的分析师行...
登录免费看全文
登录/注册